Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529346310> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2529346310 endingPage "1121" @default.
- W2529346310 startingPage "1117" @default.
- W2529346310 abstract "Prostate-specific antigen (PSA) is a well-known biomarker for prostate-cancer diagnosis. However, the serum PSA measurement alone is insufficient for accurate diagnoses because the correlation with cancer is weak within the gray zone-the biomarker level range wherein a clear-cut diagnosis is impossible. As such, accurate prostate cancer diagnosis has been supplemented by measurements of the ratio of two types of PSA: free PSA (fPSA) and complexed PSA (cPSA; α-1-antichymotrypsin-bound PSA). Herein, we describe a new method for measuring the ratio of these two types of PSA by using gold nanoparticles (AuNPs) and biochips. Both types of PSA in a sample are captured by the antibody immobilized on a biochip based on self-assembled monolayers on gold. fPSA and cPSA on the biochip are then distinguished by AuNPs that present antibodies against fPSA and cPSA, respectively. The presence of PSAs in a sample is detected with laser desorption/ionization time-of-flight mass spectrometry by observing reporter molecules, called amplification tags (Am-tags), on the AuNPs. One of the reporter molecules is an Am-tag without isotope labeling, and the other is a deuterium-labeled Am-tag (dAm-tag). These tags amplify mass signals so as to enhance the sensitivity of the method. A comparison of the mass intensities between the Am-tag and dAm-tag signals allows the determination of the ratio between fPSA and cPSA. We validated the selective measurement of fPSA and cPSA at different ratios in 50, 75, and 100 pM of total PSA (fPSA + cPSA) solutions corresponding to the gray zone in prostate-cancer diagnosis (4 - 10 ng/mL). Finally, the two types of PSA were spiked in fetal bovine serum at various ratios, and our strategy greatly afforded their accurate ratios as spiked based on a constructed calibration curve. These results clearly indicate that the strategy is applicable to human serum as a diagnostic and prognostic assay for prostate cancer." @default.
- W2529346310 created "2016-10-14" @default.
- W2529346310 creator A5009018444 @default.
- W2529346310 creator A5060167401 @default.
- W2529346310 date "2016-10-01" @default.
- W2529346310 modified "2023-09-28" @default.
- W2529346310 title "Determining the Ratio of Two Types of Prostate Specific Antigens with Biochips and Gold Nanoparticles for Accurate Prostate Cancer Diagnosis" @default.
- W2529346310 cites W1964690085 @default.
- W2529346310 cites W1968314500 @default.
- W2529346310 cites W1976165472 @default.
- W2529346310 cites W2002384741 @default.
- W2529346310 cites W2004944700 @default.
- W2529346310 cites W2014091393 @default.
- W2529346310 cites W2022834539 @default.
- W2529346310 cites W2043339016 @default.
- W2529346310 cites W2045083953 @default.
- W2529346310 cites W2067530870 @default.
- W2529346310 cites W2068743308 @default.
- W2529346310 cites W2075491385 @default.
- W2529346310 cites W2085089074 @default.
- W2529346310 cites W2090163743 @default.
- W2529346310 cites W2098423787 @default.
- W2529346310 cites W2140687262 @default.
- W2529346310 cites W2151091553 @default.
- W2529346310 cites W2164405426 @default.
- W2529346310 cites W2171655721 @default.
- W2529346310 cites W4242570784 @default.
- W2529346310 doi "https://doi.org/10.2116/analsci.32.1117" @default.
- W2529346310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27725614" @default.
- W2529346310 hasPublicationYear "2016" @default.
- W2529346310 type Work @default.
- W2529346310 sameAs 2529346310 @default.
- W2529346310 citedByCount "7" @default.
- W2529346310 countsByYear W25293463102017 @default.
- W2529346310 countsByYear W25293463102018 @default.
- W2529346310 countsByYear W25293463102020 @default.
- W2529346310 countsByYear W25293463102022 @default.
- W2529346310 crossrefType "journal-article" @default.
- W2529346310 hasAuthorship W2529346310A5009018444 @default.
- W2529346310 hasAuthorship W2529346310A5060167401 @default.
- W2529346310 hasBestOaLocation W25293463101 @default.
- W2529346310 hasConcept C104819515 @default.
- W2529346310 hasConcept C121608353 @default.
- W2529346310 hasConcept C126322002 @default.
- W2529346310 hasConcept C155672457 @default.
- W2529346310 hasConcept C159654299 @default.
- W2529346310 hasConcept C171250308 @default.
- W2529346310 hasConcept C185592680 @default.
- W2529346310 hasConcept C192562407 @default.
- W2529346310 hasConcept C203014093 @default.
- W2529346310 hasConcept C2776235491 @default.
- W2529346310 hasConcept C2780192828 @default.
- W2529346310 hasConcept C2780420688 @default.
- W2529346310 hasConcept C2781197716 @default.
- W2529346310 hasConcept C2781406297 @default.
- W2529346310 hasConcept C55493867 @default.
- W2529346310 hasConcept C71924100 @default.
- W2529346310 hasConcept C87892846 @default.
- W2529346310 hasConceptScore W2529346310C104819515 @default.
- W2529346310 hasConceptScore W2529346310C121608353 @default.
- W2529346310 hasConceptScore W2529346310C126322002 @default.
- W2529346310 hasConceptScore W2529346310C155672457 @default.
- W2529346310 hasConceptScore W2529346310C159654299 @default.
- W2529346310 hasConceptScore W2529346310C171250308 @default.
- W2529346310 hasConceptScore W2529346310C185592680 @default.
- W2529346310 hasConceptScore W2529346310C192562407 @default.
- W2529346310 hasConceptScore W2529346310C203014093 @default.
- W2529346310 hasConceptScore W2529346310C2776235491 @default.
- W2529346310 hasConceptScore W2529346310C2780192828 @default.
- W2529346310 hasConceptScore W2529346310C2780420688 @default.
- W2529346310 hasConceptScore W2529346310C2781197716 @default.
- W2529346310 hasConceptScore W2529346310C2781406297 @default.
- W2529346310 hasConceptScore W2529346310C55493867 @default.
- W2529346310 hasConceptScore W2529346310C71924100 @default.
- W2529346310 hasConceptScore W2529346310C87892846 @default.
- W2529346310 hasIssue "10" @default.
- W2529346310 hasLocation W25293463101 @default.
- W2529346310 hasLocation W25293463102 @default.
- W2529346310 hasOpenAccess W2529346310 @default.
- W2529346310 hasPrimaryLocation W25293463101 @default.
- W2529346310 hasRelatedWork W1497253641 @default.
- W2529346310 hasRelatedWork W1532628467 @default.
- W2529346310 hasRelatedWork W1980245127 @default.
- W2529346310 hasRelatedWork W2042911820 @default.
- W2529346310 hasRelatedWork W2082053935 @default.
- W2529346310 hasRelatedWork W2147707434 @default.
- W2529346310 hasRelatedWork W2897445903 @default.
- W2529346310 hasRelatedWork W3195749948 @default.
- W2529346310 hasRelatedWork W4282843086 @default.
- W2529346310 hasRelatedWork W4307545828 @default.
- W2529346310 hasVolume "32" @default.
- W2529346310 isParatext "false" @default.
- W2529346310 isRetracted "false" @default.
- W2529346310 magId "2529346310" @default.
- W2529346310 workType "article" @default.